InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Abernethy Matt, Chief Financial Officer. Officer active across 1 company, notably Neurocrine Biosciences INC. Aggregated, 26 disclosures have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €1.4m. Activity tracked since 1 December 2021. The latest transaction was filed on 4 March 2026 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Abernethy Matt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
2,249 shares0Common StockSEC:0001724097-26-000007:0
1,151 shares@ US$123.102.5% of flowCommon StockSEC:0001724097-26-000005:1
1,210 shares@ US$124.122.6% of flowCommon StockSEC:0001724097-26-000005:3
1,385 shares@ US$124.123.0% of flowCommon StockSEC:0001724097-26-000005:5
5,378 shares@ US$124.1211.7% of flowCommon StockSEC:0001724097-26-000005:7
2,133 shares0Common StockSEC:0001724097-26-000005:0
2,241 shares0Common StockSEC:0001724097-26-000005:2
2,566 shares0Common StockSEC:0001724097-26-000005:4
9,968 shares0Common StockSEC:0001724097-26-000005:6
1,368 shares@ US$136.063.2% of flowCommon StockSEC:0001724097-26-000003:1
2,437 shares0Common StockSEC:0001724097-26-000003:0
2,566 shares0Common StockSEC:0000914475-25-000055:0
1,860 shares0Common StockSEC:0000914475-25-000046:0
1,283 shares@ US$152.87283.9% of flowCommon StockSEC:0000914475-25-000020:1
2,436 shares0Common StockSEC:0000914475-25-000020:0
14,100 shares@ US$73.6019.6% of flowCommon StockSEC:0000914475-24-000193:0
900 shares@ US$73.601.3% of flowCommon StockSEC:0000914475-24-000170:0
15,000 shares@ US$73.6021.2% of flowCommon StockSEC:0000914475-24-000121:0
1,352 shares@ US$132.84883.5% of flowCommon StockSEC:0000914475-24-000067:0
1,280 shares@ US$142.18783.5% of flowCommon StockSEC:0000914475-24-000043:0
1,283 shares@ US$140.71613.5% of flowCommon StockSEC:0000914475-24-000022:0
2,132 shares@ US$107.39144.4% of flowCommon StockSEC:0001209191-23-047127:0
1,280 shares@ US$105.66672.6% of flowCommon StockSEC:0001209191-23-007905:0
1,283 shares@ US$109.98272.7% of flowCommon StockSEC:0001209191-23-006256:0
2,030 shares@ US$80.8043.1% of flowCommon StockSEC:0001209191-22-008203:0
25 of 26 declarations
About Abernethy Matt
ABERNETHY MATT is Directeur Financier and Chief Financial Officer at Neurocrine Biosciences INC, on XNAS. He has 26 filings in total, and among the sampled recent filings, the sell amount is EUR 1419873 between 2021-12-03 and 2026-03-05, with Levée d'options as the most common transaction type.
